Circulating hormone adrenomedullin and its binding protein protect neural cells from hypoxia-induced apoptosis

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 5, 2009, Pages 361-367

  Wang, Stephanie M ^a   Yang, Weng Lang ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Adrenomedullin; Adrenomedullin binding protein 1; Apoptosis; cAMP; Hypoxia; Neural cell; Protein kinase A

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENOMEDULLIN; AMBP 1; AMBP1 PROTEIN; CASPASE 3; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; HORMONE BINDING PROTEIN; KT 5720; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL COUNT; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LEVEL; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL; NERVE CELL LESION; NEUROBLASTOMA CELL; NEUROPROTECTION; NICK END LABELING; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADRENOMEDULLIN; APOPTOSIS; CASPASE 3; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE, TUMOR; COMPLEMENT FACTOR H; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOPROTECTION; DNA DAMAGE; FORSKOLIN; HUMANS; INTRACELLULAR SPACE; L-LACTATE DEHYDROGENASE; MODELS, BIOLOGICAL; NEURONS; PROTEIN KINASE INHIBITORS;

EID: 67349118889     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.03.012     Document Type: Article

References (47)

1. Kochanek P.M., Berger R.P., Bayir H., Wagner A.K., Jenkins L.W., and Clark R.S. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr. Opin. Crit. Care 14 (2008) 135-141
2. Doyle K.P., Simon R.P., and Stenzel-Poore M.P. Mechanisms of ischemic brain damage. Neuropharmacology 55 (2008) 310-318
3. Graham S.H., and Chen J. Programmed cell death in cerebral ischemia. J Cereb. Blood Flow Metab. 21 (2001) 99-109
4. Northington F.J., Ferriero D.M., Flock D.L., and Martin L.J. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J. Neurosci. 21 (2001) 1931-1938
5. Kato H., and Kogure K. Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cell Mol. Neurobiol. 19 (1999) 93-108
6. Newcomb J.D., Ajmo Jr. C.T., Sanberg C.D., Sanberg P.R., Pennypacker K.R., and Willing A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant 15 (2006) 213-223
7. Ferrer I. Apoptosis: future targets for neuroprotective strategies. Cerebrovasc. Dis. 21 Suppl 2 (2006) 9-20
8. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., and Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192 (1993) 553-560
9. Hinson J.P., Kapas S., and Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21 (2000) 138-167
10. Elsasser T.H., Kahl S., Martinez A., Montuenga L.M., Pio R., and Cuttitta F. Adrenomedullin binding protein in the plasma of multiple species: characterization by radioligand blotting. Endocrinol. 140 (1999) 4908-4911
11. Pio R., Martinez A., Unsworth E.J., Kowalak J.A., Bengoechea J.A., Zipfel P.F., Elsasser T.H., and Cuttitta F. Complement factor H is a serum binding protein for adrenomedullin. The resulting complex modulates the bioactivities of both partners. J. Biol. Chem. 276 (2001) 12292-12300
12. Zudaire E., Cuttitta F., and Martinez A. Regulation of pancreatic physiology by adrenomedullin and its binding protein. Regul. Pept. 112 (2003) 121-130
13. Carrizo G.J., Wu R., Cui X., Dwivedi A.J., Simms H.H., and Wang P. Adrenomedullin and adrenomedullin-binding protein-1 downregulate inflammatory cytokines and attenuate tissue injury after gut ischemia-reperfusion. Surgery 141 (2007) 245-253
14. Wu R., Dong W., Zhou M., Cui X., Simms H.H., and Wang P. A novel approach to maintaining cardiovascular stability after hemorrhagic shock: beneficial effects of adrenomedullin and its binding protein. Surgery 137 (2005) 200-208
15. Adem A., Mattsson M.E., Nordberg A., and Pahlman S. Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Brain Res. 430 (1987) 235-242
16. Garnier P., Ying W., and Swanson R.A. Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1. J. Neurosci. 23 (2003) 7967-7973
17. Baines C.P., Kaiser R.A., Sheiko T., Craigen W.J., and Molkentin J.D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell Biol. 9 (2007) 550-555
18. Wu R., Zhou M., and Wang P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul. Pept. 112 (2003) 19-26
19. Yata K., Matchett G.A., Tsubokawa T., Tang J., Kanamaru K., and Zhang J.H. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res. 1145 (2007) 227-238
20. Insel P.A., and Ostrom R.S. Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol. Neurobiol. 23 (2003) 305-314
21. Waltereit R., and Weller M. Signaling from cAMP/PKA to MAPK and synaptic plasticity. Mol. Neurobiol. 27 (2003) 99-106
22. Zhou M., Chaudry I.H., and Wang P. The small intestine is an important source of adrenomedullin release during polymicrobial sepsis. Am. J. Physiol Regul. Integr. Comp. Physiol. 281 (2001) R654-R660
23. Serrano J., Uttenthal L.O., Martinez A., Fernandez A.P., Martinez D., Alonso V.D., Bentura M.L., Santacana M., Gallardo J.R., Martinez-Murillo R., Cuttitta F., and Rodrigo J. Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy. Brain Res. 853 (2000) 245-268
24. Shan J., and Krukoff T.L. Distribution of preproadrenomedullin mRNA in the rat central nervous system and its modulation by physiological stressors. J. Comp. Neurol. 432 (2001) 88-100
25. Shan J., Stachniak T., Jhamandas J.H., and Krukoff T.L. Autonomic and neuroendocrine actions of adrenomedullin in the brain: mechanisms for homeostasis. Regul. Pept. 112 (2003) 33-40
26. Schwaeble W., Zwirner J., Schulz T.F., Linke R.P., Dierich M.P., and Weiss E.H. Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur. J. Immunol. 17 (1987) 1485-1489
27. Serrano J., Encinas J.M., Fernandez A.P., Castro-Blanco S., Alonso D., Fernandez-Vizarra P., Richart A., Bentura M.L., Santacana M., Cuttitta F., Martinez A., and Rodrigo J. Distribution of immunoreactivity for the adrenomedullin binding protein, complement factor H, in the rat brain. Neuroscience 116 (2003) 947-962
28. Brooimans R.A., van der Ark A.A., Buurman W.A., van Es L.A., and Daha M.R. Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1. J. Immunol. 144 (1990) 3835-3840
29. Dwivedi A.J., Wu R., Nguyen E., Higuchi S., Wang H., Krishnasastry K., Marini C.P., Ravikumar T.S., and Wang P. Adrenomedullin and adrenomedullin binding protein-1 prevent acute lung injury after gut ischemia-reperfusion. J. Am. Coll. Surg. 205 (2007) 284-293
30. Pan W., and Kastin A.J. Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog. Neurobiol. 83 (2007) 363-374
31. Menzies S.A., Betz A.L., and Hoff J.T. Contributions of ions and albumin to the formation and resolution of ischemic brain edema. J. Neurosurg. 78 (1993) 257-266
32. Ornan D.A., Chaudry I.H., and Wang P. Pulmonary clearance of adrenomedullin is reduced during the late stage of sepsis. Biochim. Biophys. Acta 1427 (1999) 315-321
33. Maiti P., Singh S.B., Mallick B., Muthuraju S., and Ilavazhagan G. High altitude memory impairment is due to neuronal apoptosis in hippocampus, cortex and striatum. J. Chem. Neuroanat. 36 (2008) 227-238
34. Filippatos G.S., Gangopadhyay N., Lalude O., Parameswaran N., Said S.I., Spielman W., and Uhal B.D. Regulation of apoptosis by vasoactive peptides. Am. J. Physiol Lung Cell Mol. Physiol. 281 (2001) L749-L761
35. Kohli V., Selzner M., Madden J.F., Bentley R.C., and Clavien P.A. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 67 (1999) 1099-1105
36. Scarabelli T., Stephanou A., Rayment N., Pasini E., Comini L., Curello S., Ferrari R., Knight R., and Latchman D. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104 (2001) 253-256
37. Hotchkiss R.S., Chang K.C., Swanson P.E., Tinsley K.W., Hui J.J., Klender P., Xanthoudakis S., Roy S., Black C., Grimm E., Aspiotis R., Han Y., Nicholson D.W., and Karl I.E. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1 (2000) 496-501
38. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., Muff R., Fischer J.A., and Foord S.M. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 54 (2002) 233-246
39. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., and Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 (1998) 333-339
40. Kamitani S., Asakawa M., Shimekake Y., Kuwasako K., Nakahara K., and Sakata T. The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells. FEBS Lett. 448 (1999) 111-114
41. Nikitenko L.L., Fox S.B., Kehoe S., Rees M.C., and Bicknell R. Adrenomedullin and tumour angiogenesis. Br. J. Cancer 94 (2006) 1-7
42. Withers D.J., Coppock H.A., Seufferlein T., Smith D.M., Bloom S.R., and Rozengurt E. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett. 378 (1996) 83-87
43. Miyashita K., Itoh H., Sawada N., Fukunaga Y., Sone M., Yamahara K., Yurugi T., and Nakao K. Adrenomedullin promotes proliferation and migration of cultured endothelial cells. Hypertens. Res. 26 Suppl (2003) S93-S98
44. Chini E.N., Chini C.C., Bolliger C., Jougasaki M., Grande J.P., Burnett Jr. J.C., and Dousa T.P. Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway. Kidney Int. 52 (1997) 917-925
45. Miyashita K., Itoh H., Sawada N., Fukunaga Y., Sone M., Yamahara K., Yurugi-Kobayashi T., Park K., and Nakao K. Adrenomedullin provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo. FEBS Lett. 544 (2003) 86-92
46. Jiao S., Liu Z., Ren W.H., Ding Y., Zhang Y.Q., Zhang Z.H., and Mei Y.A. cAMP/protein kinase A signalling pathway protects against neuronal apoptosis and is associated with modulation of Kv2.1 in cerebellar granule cells. J. Neurochem. 100 (2007) 979-991
47. Wang X., Tang X., Li M., Marshall J., and Mao Z. Regulation of neuroprotective activity of myocyte-enhancer factor 2 by cAMP-protein kinase A signaling pathway in neuronal survival. J Biol. Chem. 280 (2005) 16705-16713